Cargando…
Pharmacologic Therapy for COVID-19 Infection
The COVID-19 pandemic has focused attention on issues of epidemiology, public health, and vaccine design. I submit that attention to COVID-19 pharmacologic therapy needs similar emphasis, including identifying any existing medications that can be repurposed to treat COVID-19 patients.
Autor principal: | Nusbaum, Neil |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7169637/ https://www.ncbi.nlm.nih.gov/pubmed/32314081 http://dx.doi.org/10.1007/s10900-020-00821-z |
Ejemplares similares
-
Evaluation of the Pharmacologic Treatment of COVID-19 Pandemic in Iraq
por: Darweesh, Omeed, et al.
Publicado: (2021) -
Repurposing exercise training and pharmacological therapies to address the post-acute sequelae of COVID-19 (PASC) in diabetes mellitus
por: Jie Chee, Ying, et al.
Publicado: (2023) -
Antithrombotic therapy in COVID-19
por: Saeed, Sahrai, et al.
Publicado: (2021) -
Novel Coronavirus Disease (COVID-19) and Biologic Therapy in Psoriasis: Infection Risk and Patient Counseling in Uncertain Times
por: Brownstone, Nicholas D., et al.
Publicado: (2020) -
Targeting mucin hypersecretion in COVID-19 therapy
por: Prasher, Parteek, et al.
Publicado: (2022)